Impact of remdesivir on 28 day mortality in hospitalized patients with COVID-19: February 2021 Meta-analysis

Robert Robinson, Vidhya Prakash, Raad Al Tamimi, Nour Albast, Basma Al-Bast, Elizabeth Wieland, Carlos Garcia
doi: https://doi.org/10.1101/2021.03.04.21252903

Article usage

Article usage: March 2021 to November 2024

AbstractFullPdf
Mar 202158624100
Apr 20213171549
May 2021224929
Jun 2021121321
Jul 2021109922
Aug 20211721132
Sep 2021125236
Oct 2021127529
Nov 2021149328
Dec 2021101118
Jan 202210559
Feb 202294319
Mar 202294014
Apr 20227025
May 20227609
Jun 2022101065
Jul 202269059
Aug 20224626
Sep 202262110
Oct 20227508
Nov 20224613
Dec 202257214
Jan 20233146
Feb 20234944
Mar 20238021
Apr 20233716
May 20233216
Jun 20233046
Jul 20232317
Aug 202327107
Sep 20232143
Oct 20232203
Nov 20232475
Dec 20232602
Jan 20241204
Feb 20241804
Mar 20242975
Apr 20241996
May 20241403
Jun 20243315
Jul 20241215
Aug 202414112
Sep 20242749
Oct 20241612
Nov 202414410
Back to top
Posted March 08, 2021.
Download PDF
Data/Code
Email
Impact of remdesivir on 28 day mortality in hospitalized patients with COVID-19: February 2021 Meta-analysis
Robert Robinson, Vidhya Prakash, Raad Al Tamimi, Nour Albast, Basma Al-Bast, Elizabeth Wieland, Carlos Garcia
medRxiv 2021.03.04.21252903; doi: https://doi.org/10.1101/2021.03.04.21252903
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area